Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 Next >
Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data
Tags Biotech and Pharmaceuticals Business News Business
From CNBC.com News
Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial
Tags Biotechnology Novo Nordisk A/S Eli Lilly and Co
From CNBC.com News
Wegovy rival to be part of a suite of weight loss drugs, Roche CEO says following positive trial results
Tags Pharmaceuticals Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
Tags Novo Nordisk A/S Johnson & Johnson Bristol/Myers Squibb Co
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug wins UK approval for use as a heart treatment
Tags Health & Science Health care industry Pharmaceuticals
From CNBC.com News
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Tags Business News Business Zealand Pharma A/S
From CNBC.com News
Healthy Returns: Diabetes drug Ozempic may lower dementia risk, nicotine use
Tags UnitedHealth Group Inc Biotech and Pharmaceuticals Healthy Returns
From CNBC.com News
Healthy Returns: Drugmakers are racing to develop more convenient weight loss pills
Tags Novo Nordisk A/S Eli Lilly and Co Health care industry
From CNBC.com News
Pfizer moves forward with once-daily version of weight loss pill after setbacks
Tags Biotech and Pharmaceuticals Pfizer Inc Business
From CNBC.com News
Jim Cramer on Hims & Hers Health stock: 'I bet the business stays strong'
Tags Stock markets Business News Hims & Hers Health Inc
From CNBC.com News
FTC to sue drug middlemen over prices of medications including insulin
Tags Breaking News: Politics Biotech and Pharmaceuticals Social issues
From CNBC.com News
CNBC Daily Open: French left-wing shock victory, Boeing guilty plea
Tickers LAWS
Tags Government and politics Laws Markets
From CNBC.com News
CNBC Daily Open: French far-right advance blocked
Tags Economic events Economic policy Cryptocurrency
From CNBC.com News
This ETF is trying to satisfy appetites for weight loss stocks
Tags Health care costs Stock markets Prescription drugs
From CNBC.com News
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Tags Biotech and Pharmaceuticals Health & Science Pharmaceuticals
From CNBC.com News
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Tags Biotech and Pharmaceuticals Technology Healthy Returns
From CNBC.com News
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Tags Science Health care industry Gilead Sciences Inc
From CNBC.com News
5 things to know before the stock market opens
Tags Investing Politics Nasdaq Inc
From CNBC.com News
Novo Nordisk's Wegovy weight loss drug approved in China
Tags Europe News Biotech and Pharmaceuticals Business
From CNBC.com News
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
Tags US: News Eli Lilly and Co Companies
From CNBC.com News
Weight loss drug contender Zealand Pharma jumps 23% on trial results
Tags Zealand Pharma A/S Pharmaceuticals Europe News
From CNBC.com News
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss
Tags Labor economy Biotech and Pharmaceuticals Healthy Returns
From CNBC.com News
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
Tags Health & Science Business News Pharmaceuticals
From CNBC.com News
European stocks set for muted open after European Central Bank cut
Tags Government and politics World economy World Economy
From CNBC.com News
Why half of all workers may struggle to get weight-loss drug health insurance coverage
Tags Health care industry Health Insurance Small Business
From CNBC.com News
Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
Tags Health & Science Business Business News
From CNBC.com News
Cramer's Lightning Round: Apple is a buy
Tags Stock markets Axcelis Technologies Inc Bristol/Myers Squibb Co
From CNBC.com News
This new weight loss drug ETF bets big on two of the industry's leading players
Tags Novo Nordisk A/S Investing Chugai Pharmaceutical Co Ltd
From CNBC.com News
How digital health companies are capitalizing on the GLP-1 boom
Tags Health & Science Mobile Hims & Hers Health Inc
From CNBC.com News
Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
Tags Science Eli Lilly and Co Health care industry
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.